Else Nutrition Holdings Inc (BABYF)

[pual]

Else Nutrition Successfully Completes First Production Trial Run of its Novel, Plant-Based Infant Formula - 10/13/2021 7:00:00 AM

VANCOUVER, British Columbia, Oct. 13, 2021 (GLOBE NEWSWIRE) -- ELSE NUTRITION HOLDINGS INC. (BABY.V) (BABYF) (0YL.F) ("Else" or the "Company") the Plant-Based baby, toddler and children nutrition company, today announced that is has successfully completed its first commercial trial run of its patented, Plant-Based Infant Formula for age 0 -12 months as the Company continues its path for regulatory approval.

The trial run, which took place this week in the U.S., leveraged a global, first-of-its kind technological development with one of the raw ingredients in the Plant-Based formulation. This patented processing method results in a cleaner ingredient, while keeping the nutritional value fully intact.

“This successful trial is a major step for the Company, as we move forward to provide real choice when it comes to dairy-free infant formula,” said Hamutal Yitzhak, CEO & Co-Founder of Else Nutrition. “The $90 billion global infant formula market has been dominated by dairy and soy for too long. This development brings us one step closer to commercializing a minimally processed, Plant-Based option to millions of wanting families globally,” she added.